Associate Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark
Associate Professor Andreas Hougaard Laustsen heads the Tropical Pharmacology Lab at the Department of Biotechnology and Biomedicine, Technical University of Denmark. He is specialized in antibody discovery, toxinology, antivenom, and neglected tropical diseases. Andreas is an Advisor to the WHO’s Working Group on Snakebite Envenoming, and he is a co-founder of the biotech companies Biosyntia (synthetic biology and metabolic engineering), VenomAb (recombinant antivenoms), Antag Therapeutics (metabolic diseases), Chromologics (fermented food colors), Bactolife (infectious diseases), and VenomAid Diagnostics (snakebite diagnostics). Andreas is recognized as Denmark’s Coolest Engineer, a Top 6 Academic Entrepreneur under 35 in Europe 2017, and he was on Forbes 30 under 30 list for 2017 and MIT Technology Review’s list of the 35 Top Innovators under 35 in Europe 2017.
Mar 18, 2024 09:00 am UTC| Insights & Views Health
Snakebites kill over 100,000 people each year, and hundreds of thousands of survivors are left with long-term disabilities such as amputations. Africa, Asia and Latin America are the regions most heavily affected. The...
Electricity from farm waste: how biogas could help Malawians with no power
What the Supreme Court is doing right in considering Trump’s immunity case
US student Gaza protests: five things that have been missed
Will Solomon Islands’ new leader stay close to China?
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects